The Garvan Institute is a national and international leader in medical research.
We have a strong history of both scientific and commercial collaboration — some of our discoveries have led to new companies like G2 Therapies and Solvanix.
Our approach to partnering is flexible and commercially-focused. We recognise the essential role industry plays in pharmaceutical and diagnostic R&D. This helps us to achieve the goal of preventing and curing human disease.
We are able to provide access to our world-leading expertise and facilities and will work with industry to further our translational mission. This can be realised through:
- engaging in collaborative R&D projects
- performing contract research
- licensing our Intellectual property to entrepreneurs and to industry partners
- helping to found and attract investment to spin-off companies developing new products based on our unique contributions.